Active smoking compromises IVF outcome and affects ovarian reserve

被引:140
作者
Freour, Thomas [1 ]
Masson, Damien [2 ]
Mirallie, Sophie [1 ]
Jean, Miguel [1 ]
Bach, Kalyane [2 ]
Dejoie, Thomas [2 ]
Barriere, Paul [1 ]
机构
[1] CHU Nantes, Dept Human Reprod, Nantes, France
[2] CHU Nantes, Hormonal & Biochem Lab, Nantes, France
关键词
active smoking; anti-Mullerian hormone; IVF; ovarian reserve;
D O I
10.1016/S1472-6483(10)60561-5
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Although the association between smoking and female infertility is now largely demonstrated, the proportion of smokers in women of reproductive age remains important. Tobacco contains numerous toxicants that could affect ovarian reserve and lead to poor prognosis in assisted reproductive techniques. To investigate the effect of female active smoking on ovarian reserve and IVF outcome, smoking status, hormonal status, i.e. serum FSH, oestradiol and anti-Mullerian hormone (AMH), ovarian response to hyperstimulation, i.e. mature oocytes retrieved, and IVF outcome, i.e. clinical pregnancy, were retrospectively analysed in 111 women undergoing IVF-embryo transfer cycles. Compared with non-smokers (n = 71), active smoking women (n = 40) had decreased ovarian response (12.12 +/- 5 versus 8.62 +/- 4 mature oocytes retrieved) to hyperstimulation and lower clinical pregnancy rate (29.6 versus 10.0%). Serum AMH concentrations were lower in the smoker group (3.86 +/- 1.92 versus 3.06 +/- 1.68 mu g/l) and had no predictive value for ovarian response, inversely to non-smokers. In conclusion, active smoking is associated with poor prognosis in assisted reproduction cycles, i.e. ovarian response and pregnancy, and leads to altered ovarian reserve, as reflected by decreased serum AMH concentrations.
引用
收藏
页码:96 / 102
页数:7
相关论文
共 41 条
[1]   Smoking and female infertility: a systematic review and meta-analysis [J].
Augood, C ;
Duckitt, K ;
Templeton, AA .
HUMAN REPRODUCTION, 1998, 13 (06) :1532-1539
[2]   Relationship between epidemiological features and aetiology of male infertility as diagnosed by a comprehensive infertility service provider [J].
Aziz, N ;
Agarwal, A ;
Nallella, KP ;
Thomas, AJ .
REPRODUCTIVE BIOMEDICINE ONLINE, 2006, 12 (02) :209-214
[3]   Influence of spermatogenic profile and meiotic abnormalities on reproductive outcome of infertile patients [J].
Barri, PN ;
Vendrell, JM ;
Martinez, F ;
Coroleu, B ;
Arán, B ;
Veiga, A .
REPRODUCTIVE BIOMEDICINE ONLINE, 2005, 10 (06) :735-739
[4]   Use of the antral follicle count to predict the outcome of assisted reproductive technologies [J].
Chang, MY ;
Chiang, CH ;
Hsieh, TT ;
Soong, YK ;
Hsu, KH .
FERTILITY AND STERILITY, 1998, 69 (03) :505-510
[5]  
CHANG SH, 2007, IN PRESS MATURITAS
[6]   Timing intrauterine insemination either 33 or 39 hours after administration of human chorionic gonadotropin yields the same pregnancy rates as after superovulation therapy [J].
Claman, P ;
Wilkie, V ;
Collins, D .
FERTILITY AND STERILITY, 2004, 82 (01) :13-16
[7]  
Crha I, 2001, Cent Eur J Public Health, V9, P64
[8]   Effect of smoking on ovarian reserve and ovarian stimulation in in-vitro fertilization and embryo transfer [J].
El-Nemr, A ;
Al-Shawaf, T ;
Sabatini, L ;
Wilson, C ;
Lower, AM ;
Grudzinskas, JG .
HUMAN REPRODUCTION, 1998, 13 (08) :2192-2198
[9]   Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3 [J].
Fanchin, R ;
Schonäuer, LM ;
Righini, C ;
Guibourdenche, J ;
Frydman, R ;
Taieb, J .
HUMAN REPRODUCTION, 2003, 18 (02) :323-327
[10]   Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol [J].
Hazout, A ;
Bouchard, P ;
Seifer, DB ;
Aussage, P ;
Junca, AM ;
Cohen-Bacrie, P .
FERTILITY AND STERILITY, 2004, 82 (05) :1323-1329